Text Size
57 studies found for:    Echocardiography | Open Studies | NIH, U.S. Fed

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † Evaluating a New Echocardiography Imaging Procedure for Evaluating Heart Function
Conditions: Ischemia;   Myocardial Infarction;   Ischemic Heart Disease
Intervention:
2 Recruiting New Techniques to Evaluate Mitral Regurgitation
Condition: Mitral Valve Regurgitation
Intervention:
3 Not yet recruiting Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-related Cardiomyopathy
Conditions: T-cell Acute Lymphoblastic Leukemia;   Intermediate/Advanced Hodgkins;   Early Hodgkins
Interventions: Other: Diagnostic/symptom checklist;   Other: Anthropometry;   Procedure: Echocardiogram;   Procedure: Serum Biomarkers;   Other: 6 minute walk test (6MWT);   Behavioral: Participant Questionnaires (ages ≥14 years only)
4 Recruiting Thyroid and Glucose and Energy Metabolism
Conditions: Thyroid Diseases;   Thyroidectomy;   Replacement Thyroid Hormone Therapy;   Near Total Thyroidectomy
Interventions: Drug: Liothyronine (T3);   Drug: Levothyroxine (T4)
5 Recruiting Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
Conditions: Pulmonary Hypertension;   Sickle Cell Anemia
Intervention:
6 Unknown † Validation of Minimally Invasive Ultrasound Indicator Dilution Technique in Critically Ill Children
Condition: Cardiac Output
Intervention:
7 Recruiting Alemtuzumab (Campath(Registered Trademark)) to Treat T-Large Granular Lymphocyte Leukemia
Condition: Lymphoproliferative Disorders
Intervention: Drug: Alemtuzumab (Campath)
8 Recruiting Cardiovascular Disease Screening
Conditions: Congenital Heart Disease;   Atherosclerosis;   Myocardial Ischemia;   Myocardial Infarction;   Acquired Heart Disease
Intervention:
9 Recruiting A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
Conditions: Pulmonary Arterial Hypertension;   Systemic Sclerosis;   Scleroderma Spectrum of Diseases;   Connective Tissue Disease;   Pulmonary Hypertension
Interventions: Drug: Tadalafil monotherapy;   Drug: Ambrisentan monotherapy;   Drug: tadalafil and ambrisentan
10 Recruiting Alemtuzumab to Treat Severe Aplastic Anemia
Conditions: Relapsed or Refractory Severe Aplastic Anemia;   Severe Aplastic Anemia
Intervention: Drug: Alemtuzumab (Campath(Registered Trademark))
11 Recruiting Natural History of Sickle Cell Disease and Other Hemolytic Disorders
Conditions: Hemoglobin SC Disease;   Hematologic Diseases;   Sickle Cell Anemia;   Hemolytic Anemia
Intervention:
12 Unknown † Effects of Viagra on Heart Function in Patients With Heart Failure
Conditions: Heart Failure;   Left Ventricular Dysfunction
Intervention: Drug: sildenafil
13 Recruiting Evaluation of Patients With Heart Disease Not Eligible for Research Protocols
Condition: Heart Disease
Intervention:
14 Recruiting Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack
Condition: Myocardial Infarction
Interventions: Drug: BB3;   Drug: Placebo
15 Recruiting LMB-2 to Treat Hairy Cell Leukemia
Conditions: Positive Hairy Cell Leukemia;   CD25-Expressing Hairy Cell Leukemia
Intervention: Biological: LMB-2
16 Recruiting Evaluation of Primary Chronic Autonomic Failure
Condition: Autonomic Nervous System Diseases
Intervention:
17 Recruiting ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study
Conditions: Cardiovascular Disease;   Coronary Artery Calcification
Intervention:
18 Recruiting Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome
Conditions: Li-Fraumeni Syndrome;   Cardiovascular Capacity
Intervention:
19 Recruiting Montelukast to Treat Bronchiolitis Obliterans
Conditions: Bronchiolitis Obliterans;   Chronic Graft Versus Host Disease;   Leukotriene;   Montelukast;   Stem Cell Transplant
Interventions: Drug: Montelukast sodium;   Other: Flow cytometry;   Other: Laboratory biomarker analysis;   Procedure: Quality-of-life assessment
20 Recruiting Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease
Condition: Pulmonary Hypertension
Intervention: Drug: Warfarin
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years